Literature DB >> 33851259

Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity.

Paolo Ricchi1, Silvia Costantini2, Anna Spasiano2, Patrizia Cinque2, Simona Esposito2, Aldo Filosa2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33851259     DOI： 10.1007/s00277-021-04511-1

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  2 in total

Review 1.  Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.

Authors:  W Szmuness
Journal:  Prog Med Virol       Date:  1978

2.  Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct-acting antiviral treatment: All Kagawa Liver Disease Group Study.

Authors:  Joji Tani; Asahiro Morishita; Teppei Sakamoto; Kei Takuma; Mai Nakahara; Koji Fujita; Kyoko Oura; Tomoko Tadokoro; Shima Mimura; Takako Nomura; Hirohito Yoneyama; Hideki Kobara; Takashi Himoto; Akemi Tsutsui; Tomonori Senoh; Takuya Nagano; Chikara Ogawa; Akio Moriya; Akihiro Deguchi; Kouichi Takaguchi; Tsutomu Masaki
Journal:  Oncol Lett       Date:  2020-01-23       Impact factor: 2.967
  2 in total
  1 in total

Review 1.  Iron overload disorders.

Authors:  Christine C Hsu; Nizar H Senussi; Kleber Y Fertrin; Kris V Kowdley
Journal:  Hepatol Commun       Date:  2022-06-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.